| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |